Abstract
A multimodal approach to therapy is increasingly used in treating men with advanced penile cancer. Adjuvant chemotherapy improves outcomes in chemotherapy-naïve men with node-positive positive disease, and neoadjuvant chemotherapy can downstage bulky nodal disease sufficiently to permit surgery and has the potential to offer durable long-term survival. However, there remain several unanswered questions in this field, and international collaboration in the form of clinical trials is required to optimize treatment and improve survival in men with advanced penile cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 469-479 |
Number of pages | 11 |
Journal | Urologic Clinics of North America |
Volume | 43 |
Issue number | 4 |
DOIs | |
State | Published - Nov 1 2016 |
Keywords
- Adjuvant chemotherapy
- Neoadjuvant chemotherapy
- Penile cancer
- Radiotherapy
- Survival
ASJC Scopus subject areas
- Urology